Medinet CoTSE:2370 41 Median PS Value is 円38.81 as of Jul. 13, 2026, which is 100% below its 10-year median of 1.82. GuruFocus rates TSE:2370 with a GF Score™ of 41/100 and a GF Value™ of 円41.74 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 278 Biotechnology companies, Medinet Co ranks better than 51.08% on this metric.
This valuation method assumes that the stock valuation will revert to its historical (10-Year) median in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
Median PS Value is calculated as trailing twelve months (TTM) Revenue per Share times 10-Year median PS Ratio. Medinet Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was 円3.055. Medinet Co's 10-Year median PS Ratio is 12.7038. Therefore, the Median PS Value for today is 円38.81.
As of today (2026-07-13), Medinet Co's share price is 円25.00. Medinet Co's Median PS Value is 円38.81. Therefore, Medinet Co's Price to Median PS Value for today is 0.64.
The historical rank and industry rank for Medinet Co's Median PS Value or its related term are showing as below:
TSE:2370'
s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.61 Med: 1.82 Max: 6.43
Current: 0.64
During the past 13 years, the highest Price to Median PS Value of Medinet Co was 6.43. The lowest was 0.61. And the median was 1.82.
TSE:2370's Price-to-Median-PS-Value is ranked better than 51.08% of 278
companies
in the Biotechnology industry
Industry Median: 0.65
vs TSE:2370: 0.64
Medinet Co (TSE:2370) Median PS Value Explanation
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio
is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
Medinet Co's Price to Median PS Value for today is calculated as
Price to Median PS Value
=
Share Price
/
Median PS Value
=
25.00
/
38.81
=
0.64
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medinet Co Median PS Value Related Terms
Medinet Co Median PS Value Historical Data
* Premium members only.
The historical data trend for Medinet Co's Median PS Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:2370 vs VRTX, REGN, ALNY: Median PS Value Comparison
For the Biotechnology subindustry, Medinet Co's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medinet Co Price-to-Median-PS-Value vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Medinet Co's Price-to-Median-PS-Value distribution charts can be found below:
* The bar in red indicates where Medinet Co's Price-to-Median-PS-Value falls into.
10-Year Median PS Ratio is 12.7038.
Medinet Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円3.055.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medinet Co (TSE:2370) has a Median PS Value of 円38.81 as of Jul. 13, 2026. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Medinet Co and its competitors. This is 2032% above median its historical median of 1.82. Over the past decade, Medinet Co's Median PS Value has ranged from 0.61 to 6.43. According to the industry distribution chart, Medinet Co ranks #136 out of 278 companies in the Biotechnology industry, placing it in the top 48.9%.
Is Medinet Co's Median PS Value too high?
Medinet Co's current Median PS Value of 円38.81 is 2032% above median its 10-year median of 1.82. Over the past 10 years, this metric has ranged from a low of 0.61 to a high of 6.43. Based on the distribution chart, Medinet Co ranks #136 out of 278 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Medinet Co has a GF Score™ of 41/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Medinet Co's Median PS Value compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Medinet Co ranks #136 out of 278 companies for Median PS Value. This puts Medinet Co in the upper half of its industry. The industry median Median PS Value is 0.65. Historically, Medinet Co's own Median PS Value has ranged from 0.61 to 6.43 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Median PS Value for a Biotechnology company?
The median Median PS Value among Biotechnology companies is 0.65, based on 278 companies in the industry. Companies in the top quartile (top 25%) have a Median PS Value significantly above this median, while those in the bottom quartile fall well below. However, Median PS Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Median PS Value mean?
A high Median PS Value can signal that a stock is expensive relative to its fundamentals. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Medinet Co and its competitors. For the Biotechnology industry, the median Median PS Value is 0.65 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medinet Co's current Median PS Value is 円38.81, which is 2032% above median its own 10-year median of 1.82. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medinet Co stock overvalued right now?
Based on GuruFocus' analysis, Medinet Co (TSE:2370) is currently considered Possible Value Trap. The stock's GF Value™ is 円41.74, compared to a current price of 円25.00 — trading 40.1% below its estimated fair value. The current Median PS Value is 円38.81, which is 2032% above median its 10-year median of 1.82. Medinet Co's overall GF Score™ is 41/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Median PS Value calculated?
Median PS Value is calculated from a company's financial statements. For Medinet Co (TSE:2370), the current Median PS Value is 円38.81 as of Jul. 13, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medinet Co (TSE:2370) Overvalued in 2026?
Based on GuruFocus' analysis, Medinet Co stock appears to be undervalued.
The current stock price of 円25.00 is trading 40.1% below its estimated GF Value™ of 円41.74.
GuruFocus considers Medinet Co to be Possible Value Trap.
Key valuation signals for TSE:2370:
Median PS Value: 円38.81 (2032% above median its 10-year median of 1.82)
GF Value™: 円41.74 vs. price of 円25.00 (40.1% below fair value)
No single metric tells the full story. See the TSE:2370 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medinet Co Ltd is a Japan-based Contract Development and Manufacturing Organization (CDMO). The company is engaged in the research and development of regenerative medical products, investigational products, and specified cell products. MEDINET is a one-stop regenerative medicine and cell therapy solution provider. It provides value chain solutions including personnel training, facility and equipment design, facility operations and management, preparation of standard operating procedures, logistics network, information system, purchasing and production management, quality management solutions to medical institutions, research institutions, and biopharmaceutical companies.
41GF Score
Get the complete analysis for TSE:2370
Median PS Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:2370 has been successfully added to your 
